Get started
Dogwood Therapeutics, Inc.Dogwood Therapeutics, Inc.Dogwood Therapeutics, Inc.

Dogwood Therapeutics, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

DWTX chart


Full chart

DWTX upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪10.43 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−11.17 USD
Net income (FY)
‪−12.35 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪1.56 M‬
Beta (1Y)
3.13

Employees


Employees (FY)
12
Change (1Y)
+8 +200.00%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.03 M‬ USD

About Dogwood Therapeutics, Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Gregory Duncan
Website
dwtx.com
Headquarters
Alpharetta
Founded
2012
FIGI
BBG00X0SZKJ2
Dogwood Therapeutics, Inc. is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia. The company was founded on February 28, 2012 is headquartered in Alpharetta, GA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

DWTX news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as DWTX.

Frequently Asked Questions


The current price of DWTX is 5.87 USD — it has increased by 7.51% in the past 24 hours. Watch Dogwood Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Dogwood Therapeutics, Inc. stocks are traded under the ticker DWTX.
DWTX stock has risen by 42.13% compared to the previous week, the month change is a −12.78% fall, over the last year Dogwood Therapeutics, Inc. has showed a −45.38% decrease.
We've gathered analysts' opinions on Dogwood Therapeutics, Inc. future price: according to them, DWTX price has a max estimate of 30.00 USD and a min estimate of 10.00 USD. Watch DWTX chart and read a more detailed Dogwood Therapeutics, Inc. stock forecast: see what analysts think of Dogwood Therapeutics, Inc. and suggest that you do with its stocks.
DWTX reached its all-time high on Dec 17, 2020 with the price of 417.75 USD, and its all-time low was 1.62 USD and was reached on Nov 18, 2024. View more price dynamics on DWTX chart.
See other stocks reaching their highest and lowest prices.
DWTX stock is 18.33% volatile and has beta coefficient of 3.13. Track Dogwood Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Dogwood Therapeutics, Inc. there?
Today Dogwood Therapeutics, Inc. has the market capitalization of ‪11.22 M‬, it has increased by 42.81% over the last week.
Yes, you can track Dogwood Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Dogwood Therapeutics, Inc. is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
DWTX earnings for the last quarter are −6.29 USD per share, whereas the estimation was −1.42 USD resulting in a −344.52% surprise. The estimated earnings for the next quarter are −2.09 USD per share. See more details about Dogwood Therapeutics, Inc. earnings.
Dogwood Therapeutics, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
DWTX net income for the last quarter is ‪−7.73 M‬ USD, while the quarter before that showed ‪−2.28 M‬ USD of net income which accounts for −238.84% change. Track more Dogwood Therapeutics, Inc. financial stats to get the full picture.
No, DWTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 24, 2025, the company has 12 employees. See our rating of the largest employees — is Dogwood Therapeutics, Inc. on this list?
Like other stocks, DWTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Dogwood Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Dogwood Therapeutics, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Dogwood Therapeutics, Inc. stock shows the sell signal. See more of Dogwood Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.